A global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines. Clinigen’s mission is to deliver the right medicine to the right patient at the right time, operating in three areas of global medicine supply: clinical trials, unlicensed and licensed medicines.

The global leader in the specialist management of ethical, regulatory compliant and efficient solutions to help pharmaceutical and biotech companies and healthcare professionals provide global access to medicines for patients with unmet medical need. For pharmaceutical companies, we provide solutions that enable early access (through Managed Access programs) to critical, pre-licensed, innovative medicines, extending the global reach of their medicines and providing access for patients with unmet need. For pharmacists and physicians, we enable ethical, compliant and timely access on-demand to treatments that are unlicensed or unavailable in their own country, ensuring patients are connected with the medicines they need.

The trusted partner in providing ethical, compliant access to both unlicensed and commercial medicines in the regions of Asia, Africa and Australasia, supporting healthcare professionals and pharmaceutical industry partners to provide access to specialist and difficult to access medicines.

Quantum operates through two main trading divisions (unlicensed and licensed) incorporating multiple business units across a number of locations in the UK and Europe. Quantum offers a portfolio of innovative and synergistic products and services. The two divisions cover the full unlicensed to licensed product cycle from the manufacture and supply of unlicensed medicines to the development and supply of licensed medicines.